Internuclear ophthalmoplegia

H7_INTERNUCOPHTHALMOPLEGIA

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 H51.2
  • Cause of death: ICD-10 H51.2

2 out of 7 registries used, show all original rules.

129

4. Check minimum number of events

None

129

5. Include endpoints

None

129

6. Filter based on genotype QC (FinnGen only)

129

Control definitions (FinnGen only)

Control exclude
H7_OCUMUSCLE

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H51
Name in latin
Ophthalmoplegia internuclearis

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 744 360 381
Only index persons 703 351 352
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 53.28 49.63 56.83
Only index persons 52.66 49.17 56.15

-FinnGen-

Key figures

All Female Male
Number of individuals 129 75 54
Unadjusted period prevalence (%) 0.02 0.03 0.02
Median age at first event (years) 51.03 44.39 60.26

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
110
Matched controls
1098
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H51.2
ICD-10 Finland
Internuclear ophthalmoplegia
+∞
158.7
110
*
G35
ICD-10 Finland
Multiple sclerosis
106.4
29.5
31
*
109
Kela drug reimbursment
Multiple sclerosis
159.9
24.7
25
*
H53.2
ICD-10 Finland
Diplopia
43.0
23.9
29
9
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
17.1
23.7
39
34
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
101.1
22.7
24
*
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
121.0
19.3
20
*
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
185.3
15.9
16
*
L03AX13
ATC
glatiramer acetate; parenteral
171.9
14.8
15
*
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
10.1
13.7
28
36
L03AB07
ATC
interferon beta-1a; parenteral
79.3
12.9
14
*
XCK00
NOMESCO Finland
Perimetry
12.2
12.2
22
22
TAB00
NOMESCO Finland
Lumbar puncture
12.1
11.6
21
21
AA1AD
NOMESCO Finland
CT of head and brain
4.8
11.4
44
133
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
+∞
10.6
10
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
6.9
10.2
26
47
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
7.2
9.4
23
39
N86
ICPC
Multiple sclerosis
54.4
8.8
10
*
H46
ICD-10 Finland
Optic neuritis
36.3
8.2
10
*
N07AA02
ATC
pyridostigmine; systemic
+∞
7.4
7
*
L03AB08
ATC
interferon beta-1b; parenteral
+∞
7.4
7
*
2AB04
NOMESCO Finland
NA
+∞
7.4
7
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.0
7.0
29
90
M03BX01
ATC
baclofen; systemic
24.3
6.8
9
*
G46.3*I67.9
ICD-10 Finland
Brain stem stroke syndrome (I60-I67+)
74.0
6.5
7
*
353
Kela drug reimbursment
Cladribine and fingolimod
74.0
6.5
7
*
164
Kela drug reimbursment
Fingolimod
74.0
6.5
7
*
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
7.1
6.4
15
24
G70.0
ICD-10 Finland
Myasthenia gravis
+∞
6.3
6
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
13.6
6.2
10
8
N04BB01
ATC
amantadine; oral
16.2
6.0
9
6

Mortality – FinRegistry

Association

Association between endpoint H7_INTERNUCOPHTHALMOPLEGIA and mortality.

Females

No data

Males

Parameter HR [95% CI] p-value
H7_INTERNUCOPHTHALMOPLEGIA 1.405 [1.03, 1.92] 0.033
Birth year 0.987 [0.98, 1.0] 0.007

During the follow-up period (1.1.1998 — 31.12.2019), 84 out of 347 males with H7_INTERNUCOPHTHALMOPLEGIA died.

Mortality risk

Mortality risk for people of age

years, who have H7_INTERNUCOPHTHALMOPLEGIA.

N-year risk Females Males
1 No data 0.289%
5 No data 1.514%
10 No data 3.942%
15 No data 7.271%
20 No data 12.622%

Relationships between endpoints

Index endpoint: H7_INTERNUCOPHTHALMOPLEGIA – Internuclear ophthalmoplegia

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data